Skip to main content

US FDA decision allowing COVID vaccines to infants, children mustn't happen in UK

A letter signed by 76 doctors in the U.K. to the Medical and Healthcare products Regulatory Agency (MHRA) and other U.K. Government officials laying out comprehensive reasons why the recent U.S. FDA decision authorizing COVID vaccinations in infants and young children must not happen in the UK:

We are writing to you urgently concerning the announcement that the FDA has granted an Emergency Use Authorization for both Pfizer and Moderna COVID-19 vaccines in preschool children.
We would urge you to consider very carefully the move to vaccinate ever younger children against SARS-CoV-2, despite the gradual but significant reducing virulence of successive variants, the increasing evidence of rapidly waning vaccine efficacy, the increasing concerns over long-term vaccine harms, and the knowledge that the vast majority of this young age group have already been exposed to SARS-CoV-2 repeatedly and have demonstrably effective immunity. Thus, the balance of benefit and risk which supported the rollout of mRNA vaccines to the elderly and vulnerable in 2021 is totally inappropriate for small children in 2022.
We also strongly challenge the addition of COVID-19 vaccination into the routine child immunization program despite no demonstrated clinical need, known and unknown risks (see below) and the fact that these vaccines still have only conditional marketing authorization.
It is noteworthy that the Pfizer documentation presented to the FDA has huge gaps in the evidence provided:
  • The protocol was changed mid-trial. The original two-dose schedule exhibited poor immunogenicity with efficacy far below the required standard. A third dose was added by which time many of the original placebo recipients had been vaccinated.
  • There was no statistically significant difference between the placebo and vaccinated groups in either the 6–23-month age group or the 2-4-year-olds, even after the third dose. Astonishingly, the results were based on just three participants in the younger age group (one vaccinated and two placebo) and just seven participants in the older 2–4-year-olds (two vaccinated and five placebo). Indeed, for the younger age group the confidence intervals ranged from minus-367% to plus-99%. The manufacturer stated that the numbers were too low to draw any confident conclusions. Moreover, these limited numbers come only from children infected more than seven days after the third dose.
  • Over the whole time period from the first dose onwards (see page 39 Tables 19 and 20), there were a total of 225 infected children in the vaccinated arm and 150 in the placebo arm, giving a calculated vaccine efficacy of only 25% (14% for the 6-23 months, and 33% for 2-4s).
  • The additional immunogenicity studies against Omicron, requested by the FDA, only involved a total of 66 children tested one month after the third dose (see page 35).
It is incomprehensible that the FDA considered that this represents sufficient evidence on which to base a decision to vaccinate healthy children. When it comes to safety, the data are even thinner: only 1,057 children, some already unblinded, were followed for just two months. It is noteworthy that Sweden and Norway are not recommending the vaccine for 5-11s and Holland is not recommending it for children who have already had COVID-19. The director of the Danish Health and Medicines Authority stated recently that with what is now known, the decision to vaccinate children was a mistake.
We summarize below the overwhelming arguments against this vaccination.

A. Extremely low risk from COVID-19 to young children

  • In the whole of 2020 and 2021, not a single child aged 1-9 died where COVID-19 was the sole diagnosis on the death certificate, according to ONS data.
  • A detailed study in England from March 1st 2020 to March 1st 2021 found only six children under 18 years died with no co-morbidities. There were no deaths aged 1-4 years.
  • Children clear the virus more easily than adults.
  • Children mount effective, robust, and sustained immune responses.
  • Since the arrival of the Omicron variant, infections have been generally much milder. That is also true for unvaccinated under-5s.
  • By June 2022 it is now estimated that 89% of 1-4-year-olds had already had SARS-CoV-2 infection.
  • Recent data from Israel show excellent long-lasting immunity following infection in children, especially in 5-11s.

B. Poor vaccine efficacy

  • In adults, it has become apparent that vaccine efficacy wanes steadily over time, necessitating boosters at regular intervals. Specifically, vaccine efficacy has waned more rapidly against the latest Omicron variants.
  • In children, vaccine efficacy has waned more rapidly in 5-11s than in 12-17s, possibly related to the lower dose used in the pediatric formulation. One study from New York showed efficacy against Omicron falling to only 12% by 4-5 weeks and to negative values by 5-6 weeks post second dose.
  • In the Pfizer 0-4s trial, the efficacy after two doses fell to negative values, necessitating a change to the trial protocol. After a third dose there was a suggestion of efficacy from 7-30 days but there is no data beyond 30 days to see how quickly this will wane.

C. Potential harms of COVID-19 vaccines for children

  • There has been great concern about myocarditis in adolescents and young adults, especially in males after the second dose, estimated at one per 2,600 in active post-marketing surveillance in Hong Kong. The emerging evidence of persistent cardiac abnormalities in adolescents with post-mRNA vaccine myopericarditis, as demonstrated by cardiac MRI at 3-8 months follow up, suggests this is far from ‘mild and short-lived’. The potential for longer term effects requires further study and calls for the strictest application of the precautionary principle in respect of the youngest and most vulnerable children.
  • Although post-vaccination myocarditis appears to be less common in 5-11-year-olds than older children, it is, nonetheless, increased over baseline.
  • In the Pfizer study, 50% of vaccinated children had systemic adverse events, including irritability and fever. Diagnosis of myocarditis is much more difficult in younger children. No troponin levels or ECG studies were documented. Even a vaccinated child in the trial, hospitalized with fever, calf pain and a raised CPK, had no report of D-dimers, anti-platelet antibodies or troponin levels.
  • In Pfizer’s 5-11s post-authorization conditions, it is required to conduct studies looking for myocarditis and is not due to report results until 2027.
  • Of equal concern are, as yet unknown, negative effects on the immune system. In the 0-4s trial, only seven children were described as having “severe” COVID-19 – six vaccinated and one given placebo. Similarly, for the 12 children with recurrent episodes of infection, 10 were vaccinated against only two who received placebo. These are all tiny figures and much too small to rule out any adverse impact such as antibody dependent enhancement (ADE) and other impacts on the immune system.
  • Also unanswered is the question of Original Antigenic Sin. It is of note that in a large Israeli study, those infected after vaccination had poorer cover than those vaccinated after infection. In the Moderna trial, N-antibodies were seen in only 40% of those infected after vaccination, compared with 93% of those infected after placebo.
  • There is evidence of vaccine-induced disruption of both innate and adaptive immune responses. The possibility of developing an impaired immune function would be disastrous for children, who have the most competent innate immunity, which by now has been effectively trained by the circulating virus.
  • Totally unknown is whether there will be any adverse effect on T-cell function leading to an increase in cancers.
  • Also, in terms of reproductive function, limited animal bio-distribution studies showed lipid nanoparticles concentrate in ovaries and testes. Adult sperm donors have showed a reduction in sperm counts particularly of motile sperm, falling by three months post-vaccination and remaining depressed at four to five months.
  • Even for adults, concerns are rising that serious adverse events are in excess of hospitalizations from COVID-19.

D. Informed consent

  • For 5-11s, the JCVI, in recommending a “non-urgent offer” of vaccination, specifically noted the importance of fully informed consent with no coercion.
  • With the low uptake in this age group, the presence of ‘therapy dogs’, advertisements including superhero images and information about child vaccination protecting friends and family all clearly run contrary to the concept of consent, fully informed and freely given.
  • The complete omission of information explaining to the public the different and novel technology used in COVID-19 vaccines compared to standard vaccines, and the failure to inform of the lack of any long-term safety data, borders on misinformation.

E. Effect on public confidence

  • Vaccines against much more serious diseases, such as polio and measles, need to be prioritized. Pushing an unnecessary and novel, gene-based vaccine on to young children risks seriously undermining parental confidence in the whole immunization program.
  • The poor quality of the data presented by Pfizer risks bringing the pharmaceutical industry into disrepute and the regulators if this product is authorized.
In summary, young healthy children are at minimal risk from COVID-19, especially since the arrival of the Omicron variant. Most have been repeatedly exposed to SARS-CoV-2 virus, yet have remained well, or have had short, mild illness. As detailed above, the vaccines are of brief efficacy, have known short- to medium-term risks and unknown long-term safety. Data for clinically useful efficacy in small children are scant or absent. In older children, for whom the vaccines are already licensed, they have been promoted via ethically dubious schemes to the potential detriment of other, and vital, parts of the childhood vaccination program.
For a tiny minority of children for whom the potential for benefit clearly and unequivocally outweighed the potential for harm, vaccination could have been facilitated by restrictive licenses. Whether following the precautionary principle or the instruction to First Do No Harm, such vaccines have no place in a routine childhood immunization program.

Comments

TRENDING

Global Ambedkarites in deep shock over killing of Buddhist Ambedkarite youth in Nanded

Joint  Ambedkar International Mission and Ambedkar Association of North America statement on killing of an Ambedkarite Buddhist youth for celebrating Dr Ambedkar Jayanti (birth anniversary) in his village on 1st June 2023 in Bondhar Haveli village, Nanded, Maharashtra: *** Every single public event hosted by any social or political organization in Maharashtra is not completed without citing Dr. Babasaheb Ambedkar and yet an Ambedkarite Buddhist youth, Akshay Bhalerao was brutally murdered for celebrating Dr Ambedkar Jayanti in the village Bondhar, Nanded, Maharashtra by dominant caste goons. Caste Atrocities are common in such villages where the Scheduled Castes and Buddhists are daily humiliated, mocked, or abused with caste slurs and women subjected to sexual violence. 

How this top Maoist leader couldn't extricate completely from the Left adventurist line

By Harsh Thakor  On the 31st of May Katakam Sudarshan, known as Comrade Anand, breathed his last, at the age of 69. Anand was a member of the Politburo of the Central Committee of the Communist Party of India (Maoists) and an important leader of the revolutionary movement of India.

Discussion on making school education meaningful to vulnerable communities

ActionAid note on workshop to boost National Curriculum Framework operations: *** Leading educationists and activists striving to make education meaningful to vulnerable communities gathered in Delhi to discuss the National Curriculum Framework for School Education (NCFSE). Acting in response to the call of the NCF Steering Committee appointed by the Ministry of Education, Government of India, ActionAid Association had organised the meeting to gather feedback on the draft NCFSE. This is part of ActionAid Association’s commitment to promote inclusive and gender-responsive education. The two-day national workshop titled ‘NCF Perspectives: Seeking Feedback on National Curriculum Framework (NCF)’ on May 30 and 31, 2023, was held at India International Centre, New Delhi. The workshop aimed to ensure a structured approach to gathering feedback from key stakeholders and enhancing their active participation in shaping the response sought by the Government of India. Stakeholders representing e

Abrogation of Art 370: Increasing alienation, relentless repression, simmering conflict

One year after the abrogation by the Central Government of Art. 370 in Kashmir, what is the situation in the Valley. Have the promises of peace, normalcy and development been realised? What is the current status in the Valley? Here is a detailed note by the People’s Union for Civil Liberties , “Jammu & Kashmir: One Year after Abrogation of Art. 370: Increasing Alienation, Relentless Repression, Simmering Conflict”:

Release of dabang neta: Rule of law can't be allowed to be slave to political rhetoric

By Vidya Bhushan Rawat*  When we look to politicians for solutions and politics as the 'final solution' for every evil then we are disappointed most of the time. In politics, we knowingly or unknowingly become part of the propaganda tool of the ruling elite which exists everywhere across different castes. We often provide issues and talk about them in binaries which suit our elites. The minorities among the marginalised who have no political space and representation rarely get heard by these majoritarian parties whose agenda remain power communities. Every political party in today's time is following the 'successful' formula of 'democracy' which is keeping the 'powerful' 'jaatis' with them leaving aside the marginalised one. The BJP started this but yes they cobbled together all other communities too through a diverse narrative.

J&K RTI activist denied opportunity to address audience, bring forward critical issues

Statement by Er. Irfan Banka, Founder of J&K RTI Foundation and convener of the Nalae Ferozpora Bachav Movement, regarding the incident of official misconduct during the My Town My Pride Jan Abhiyan Program and communication to Raj Bhavan: *** Er. Irfan Banka, a prominent RTI Activist and advocate, has come forward to address an incident of misconduct that occurred during the My Town My Pride Jan Abhiyan Program held at Mugam Town Hall in  Budgam. Additionally, Er. Irfan Banka has communicated the matter to Raj Bhavan, seeking appropriate action. During the event, Er. Irfan Banka was denied the opportunity to address the audience and bring forward critical issues concerning the people and services in the community, including waste management, traffic management, and the achievement of sustainable development goals. The incident involved the Additional Registrar Co-operative Kashmir, who not only prevented Er. Irfan Banka from speaking but also subjected him to public humiliation. E

Why are 17 Indian cos, including Sterlite, blacklisted by Norway bank

By Venkatesh Nayak* Readers may recall the gory incidents that took place at Thoothukudi (Tuticorin) in Tamil Nadu in the southern part of India on 22 May, 2018. Thirteen protesters died on the spot when the police opened fire to disperse an assemblage of thousands of local residents and representatives of civil society groups. They were protesting against the adverse environmental impact of the industrial operations of Sterlite Copper which runs a copper smelter plant in the area. Accusations against the company have ranged from polluting local water resources to plans for expanding the installed capacity of the plant without the necessary environmental clearances. A ground report published in The Wire recently, mentions the decision taken by Norges Bank a few years ago to not invest funds from Norway’s Government Pension Fund Global (GPFG) in Sterlite “due to an unacceptable risk of complicity in current and future severe environmental damage and systematic human rights violations

Sengol imbroglio suggests reason why Modi, BJP don't respect modern Indian history

By Vidya Bhushan Rawat*  The new parliament building opened on February 28. It looks it is not the Parliament but part of #Pratinidhisabhas ' started by earstwhile #princelystates in India. The #BJP for long has been acting as if India is a #Kingdom and Modi ji the new #King of India. Even at the coronations of Kings, you find a large number of people, and dignitaries but look at the opening ceremony we have only one face as if he build everything. Is it the dream of a republic.

Danger ahead: Smartphones making teens sexually smart, but mentally disturbed

By Harasankar Adhikari  We live in a digitally globalised society. Bombarded consumerism and imitation of foreign cultures and practises reshape our everyday lives. Life choices and lifestyles are the driving forces of modernity at present. People of almost all ages are within this realm and rhythm of consumerism for happiness.

Cave of Spleen - a feminist perspective: Status of women in early 18th century England

The Cave of Spleen: Aubrey Beardsley's illustration for Pope's “The Rape of the Lock” By Pragya Ranjan  "The Rape of the Lock" by Alexander Pope published in 1712 is a mock-heroic narrative which satirically glorifies trivial incident of cutting of locks of protagonist Belinda. This poem was written in the Augustan Era (1660-1784) which is marked by the period of scientific reason and rationality, whose effect can be seen on the writers of those times. This timeline is particularly important to analyse the episode of the Cave of Spleen.